ATHA News

In the busiest week yet for the 2020 IPO market, 15 IPOs raised $8.7 billion. Snowflake (SNOW) took the spotlight, completing the largest software IPO ever and bagging the biggest billion-dollar pop in two decades. Eight SPACs joined the week’s diverse group of IPOs. The year’s largest IPO to date, Snowflake (SNOW) priced above...read more

Athira Pharma, a Phase 2/3 biotech targeting the novel HGF/MET pathway for Alzheimer's, raised $204 million by offering 12 million shares at $17, the high end of the range of $15 to $17. The company offered 2 million more shares than anticipated. At pricing, the company raised 28% more in proceeds than expected. Athira Pharma plans to list on the Nasdaq under the symbol ATHA....read more

Athira Pharma, a Phase 2/3 biotech developing small molecule therapies for neurodegeneration, announced terms for its IPO on Monday. The Seattle, WA-based company plans to raise $160 million by offering 10 million shares at a price range of $15 to $17. At the midpoint of the proposed range, Athira Pharma would command a fully diluted market value of $480 million. The...read more

Two foreign electric vehicle makers and three SPACs went public this past week. A wave of filings brought 27 companies into the IPO pipeline. Xpeng (XPEV), a Chinese electric vehicle maker, upsized and priced above the range to raise $1.5 billion at an $11.2 billion market cap. While the company has yet to achieve positive gross margins, its P7 model has seen...read more